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Non-invasive ventilation for surgical patients with 
acute respiratory failure
Byoung Chul Lee, Kyu Hyouck Kyoung, Young Hwan Kim, Suk-Kyung Hong
Division of Trauma and Surgical Critical Care, Department of Surgery, Asan Medical Center, University of Ulsan College of 
Medicine, Seoul, Korea
Purpose: Acute respiratory failure is a relatively common complication in surgical patients, especially after abdominal 
surgery. Non-invasive ventilation (NIV) is increasingly used in the treatment of acute respiratory failure. We have assessed 
the usefulness of NIV in surgical patients with acute respiratory failure. Methods: We retrospectively reviewed the medical 
charts of patients who were admitted to a surgical intensive care unit between March 2007 and February 2008 with acute res-
piratory failure. The patients who have got respiratory care for secondary reason such as sepsis and encephalopathy were ex-
cluded from this study. Results:  Of the 74 patients who were treated with mechanical ventilation, 15 underwent NIV and 59 
underwent invasive ventilation. The causes of acute respiratory failure in the NIV group were atelectasis in 5 patients, pneu-
monia in 5, acute lung injury in 4, and pulmonary edema in 1, this group included 3 patients with acute respiratory failure af-
ter extubation. Overall success rate of NIV was 66.7%. Conclusion: NIV may be an alternative to conventional ventilation in 
surgical patients with acute respiratory failure. Use of NIV may avoid re-intubation in patients who develop respiratory fail-
ure after intubation.
Key Words: Non-invasive ventilation, Acute respiratory failure, Pulmonary atelectasis, Pneumonia, Post-operative complica-
tions
INTRODUCTION
Acute respiratory failure (ARF) is a complication in sur-
gical patients, especially after abdominal surgery. ARF af-
ter abdominal surgery is closely associated with a reduc-
tion in lung volume caused by alveolar collapse and dys-
function of the diaphragm, increased intraabdominal 
pressure after surgery, and decreased respiration caused 
by pain [1-4]. Treatment of post-operative ARF usually in-
cludes endotracheal tube insertion and mechanical ven-
tilation. 
More recently, however, patients with post-operative 
ARF have been treated by non-invasive ventilation (NIV) 
[5], consisting of attachment of a mask to the face without 
endotracheal tube insertion (Fig. 1), followed by deliveries 
of positive air pressure by pressure support ventilation 
(PSV) and positive end expiratory pressure (PEEP) or con-
tinuous positive airway pressure (CPAP) [6,7]. NIV with 
positive pressure ventilation can relieve a patient’s in-
spiratory efforts and improve gas exchange without the NIV for surgical patients with ARF
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Fig. 1. Non-invasive ventilation.
need for endotracheal intubation. This may benefit pa-
tients since endotracheal intubation has been associated 
with numerous complications. NIV decreases the devel-
opment of ventilator associated pneumonia, allows the 
patient to eat and drink while receiving positive pressure 
ventilation and decreases the use of sedative drugs and 
neuromuscular blockers required to endure mechanical 
ventilation. Consequently, NIV shortens weaning time 
from mechanical ventilators and can avoid hypotension 
caused by the use of sedatives [6].
NIV was initially applied to treat patients with chronic 
obstructive pulmonary disease. In addition to successfully 
treating ARF, NIV reduced invasive intubation and mor-
tality rates, and shortened treatment periods [8-10]. NIV 
has been utilized primarily to treat patients with hyper-
carbic respiratory failure, and its therapeutic role in treat-
ing psychogenic ARF and ARF after abdominal or thoracic 
surgery is expanding [11-15]. We therefore assessed the 
usefulness of NIV in surgical patients with ARF.
METHODS
We retrospectively reviewed the medical records of the 
medical charts of patients admitted to the surgical in-
tensive care unit in our institution for ARF between March 
2007 and February 2008.
ARF was defined as a tachypnea (respiration rate ＞35), 
hypercapnea (PaCO2 ＞45 mmHg and PH ＜7.35), hypo-
xemia (PaO2/FiO2 ＜150), severe dyspnea, and the use of 
accessory respiratory muscles. Patients were excluded if 
they had hemodynamic instability, decreased mental sta-
tus, inability to expectorate airway secretions or facial 
trauma. 
NIV was performed using Performa Trak facial masks 
(Philips Respironics, Woerden, Netherland) either pres-
sure control ventilation or PSV. Treatment goals included 
a volume per respiration of 6 to 8 mL/kg, with PEEP ad-
justed to 5 to 15 cmH2O according to the conditions of each 
patient’s lung. Arterial blood gas analysis (ABGA), respi-
ration rate and patient compliance were monitored 
continuously. NIV was converted to invasive ventilation 
with endotracheal intubation if respiratory status was 
worsened despite NIV support.
Weaning was performed using the optimal method that 
reduced the time of mechanical ventilation, including al-
ternation of mechanical ventilation with venturi masks, 
reservoir bags. Patients were extubated if they were con-
scious, could breathe on their own, could readily ex-
pectorate, and could maintain smooth tidal volume under 
a positive pressure respiration ＜8 cm H2O. 
ARF patients were divided into two groups, according 
to whether they underwent NIV or invasive ventilation. 
Their clinical features were compared including patient 
age, gender, acute physiology and chronic health evalua-
tion (APACHE) II score at the time of the application of 
mechanical ventilation, PaO2/FiO2 ratio, whether or not 
immune suppressors were used, and the cause of respira-
tory failure. Causes of respiratory failure were diagnosed 
by clinical symptoms, ABGA, and chest radiographs. 
Success of treatment was defined as weaning from me-
chanical ventilation. Multivariate logistic regression anal-
ysis was used to determine factors predictive of the suc-
cess of NIV.
RESULTS
Classification of patient groups according to un-
derlying diseases
We identified 74 patients who were treated in the surgi-Byoung Chul Lee, et al.
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Table 2. Characteristics of the patients with acute respiratory failure
Non-invasive Invasive 
ventilation ventilation P-value
(n = 15) (n = 59)
Age (yr)    56 ± 14    54 ± 18 0.13
Male 10 (66.7) 49 (83.0) 0.64
APACHE II score    14 ± 6    17 ± 6 0.2
PaO2/FiO2 115 ± 71 137 ± 69 0.4
Immunosuppressant   5 (33.3) 26 (44.1) 0.18
Etiology 0.032
　Atelectasis   5 (33.3)   5 (8.5)
　Pneumonia   5 (33.3) 36 (61.0)
　Acute lung injury   4 (26.7) 14 (23.7)
　Pulmonary edema    1 (6.6)   3 (5.0)
　Pulmonary embolism   0 (0)   1 (1.7)
Day of mechanical   6.0  ± 6.0 13.9 ± 18.0 0.62
 ventilation (day)
Day of ICU stay (day)   9.4  ± 7.6 17.6 ± 19.6 0.58
Mortality   2 (13.3) 13 (22.0) 0.32
Values are presented as mean ± SD or number (%).
APACHE, acute physiology and chronic health evaluation; ICU, 
intensive care unit.
Table 1. Underlying condition of the patients with acute respiratory
failure (n = 74)
Non-invasive Invasive 
ventilation ventilation
Use of immunosuppressant 5 12
Multiple trauma 1 5
Post-operation
　Elective surgery 9 38
　Emergency surgery 0 4
cal intensive care unit for ARF, including 45 patients who 
developed ARF immediately after elective surgery includ-
ing transplantation, 17 patients taking immune suppres-
sors after transplantation, 6 patients with multiple trau-
mas, 4 patients who developed ARF immediately after 
emergency surgery, and 2 patients who developed ARF 
during follow-up observation after surgery other than 
transplantation. Of these 74 patients, 52 (77%) developed 
acute respiratory failure within 1 month after abdominal 
surgery or multiple traumas, with ARF directly associated 
with surgery and trauma. The 17 patients who developed 
ARF while taking immune suppressors were being treated 
with the latter after organ transplantation, including liver, 
kidney, pancreas, and other organs (Table 1).
Comparison of invasive ventilation and NIV pa-
tient groups
Of the 74 ARF patients, 59 patients (79.7%) received in-
vasive ventilation, and 15 (20.3%) received NIV (Table 2). 
Mean age in the invasive ventilation and NIV groups were 
54 ± 18 years and 56 ± 14 years, respectively. The invasive 
ventilation group consisted of 39 males (66.2%) and 29 fe-
males (33.8%), whereas the NIV group consisted of 5 males 
(33.3%) and 10 females (66.7%). Causes of ARF in the in-
vasive ventilation group were pneumonia 36 patients 
(61.0%), acute lung injury 14 patients (23.7%), atelectasis 3 
patients (5.0%), pulmonary edema 3 patients (5.0%), and 
pulmonary embolism 1 patient (1.7%). Causes of ARF in 
the NIV group were atelectasis 5 patients (33.3%), pneu-
monia 5 patients (33.3%), acute lung injury 4 patients 
(26.7%), and patient with psychogenic pulmonary edema 
1 patient (6.6%). 
Of the 59 patients in the invasive ventilation group, 26 
(44.1%) were immunosuppressed. Their mean APACHE II 
score at the time of ARF development was 17 ± 6 points, 
and their mean PaO2/FiO2 was 137± 69. Of the 15 patients 
in the NIV group, 5 (33.3%) were immunosuppresed. 
Their mean APACHE II score was 14 ± 6 points, and their 
mean PaO2/FiO2 was 115 ± 71 points. 
The mean duration of artificial respirator application in 
the invasive ventilation group was 13.9 ± 18.0 days, their 
mean stay in the intensive care unit was 17.6 ± 19.6 days, 
and 13 of these 59 patients (22.0%) died. In comparison, the 
mean duration of artificial respirator application in the 
NIV group was 6.0 ± 6.0 days, their mean stay in the in-
tensive care unit was 9.4 ± 7.6 days, and 2 of these 15 pa-
tients (13.3%) died. 
Although the mean days of mechanical ventilation and 
stay in the intensive care unit differed in the two group, 
these differences were not statistically significant (P = 0.62 
and 0.58 respectively). This may have been due to the se-
verity of illness in several patients who received invasive 
ventilation requiring treatment for a long time.
Conversion from NIV to invasive ventilation
Among the 15 patients in the NIV group, 10 (66.7%) 
were treated successfully without endotracheal intuba-
tion, whereas 5 (33.3%) were converted to invasive ven-NIV for surgical patients with ARF
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Table 3. The characteristics of the patients who were converted from non-invasive ventilation to invasive ventilation
Pulmonary Duration  of  Duration  of 
   Age/Sex Diagnosis Cause Mortality
    complication NIV (hr) IV (day)
    65/F Stomach cancer Atelectasis 10   3 Hypercapnea Survive
    29/F KT status Pneumonia 10 27 Noncooperation Expire
    61/M Atherosclerosis Atelectasis 67   8 Hypoxia Survive
    63/M LT status Pneumonia 48 84 Dyspnea Survive
    74/M Stomach cancer Pulmonary edema     6 13 Noncooperation Survive
NIV, non-invasive ventilation; IV, invasive ventilation; KT, kidney transplantation; LT, liver transplantation.
Table 4. The patients with respiratory failure after extubation who were successfully weaned with non-invasive ventilation
 Age/Sex Diagnosis
Pulmonary 
complication
Duration of
IV (day)
Duration of 
NIV (day)
Extubation-NIV 
(hr)
Cause of 
conversion
     63/F Gastric cancer Atelectasis 7 1 7 Dyspnea
     70/M Hepatocellular carcinoma Atelectasis 2 2 12 Dyspnea
     38/F Multiple trauma Acute lung injury 8 2 3 Hypoxia
IV, invasive ventilation; NIV, non-invasive ventilation.
tilation during treatment. The causes of conversion in-
cluded patient noncooperation in 2 patients, the deterio-
ration of hypercapnea in 1, deterioration of hypoxia in 1, 
and dyspnea symptoms in 1 (Table 3). Causative diseases 
in these 5 patients included atelectasis in 2, pneumonia in 
2 and psychogenic pulmonary edema in 1. The mean time 
to conversion in these 5 patients was 28.2 hours after the 
start of NIV. Particularly, in patients whose causative dis-
ease was pneumonia, there was a trend toward a longer 
treatment period even after the conversion to invasive 
ventilation. 
Application of NIV to ARF patients after extuba-
tion
Of the 59 patients who received invasive ventilation, 3 
were treated by NIV for respiratory failure after ex-
tubation, thus avoiding re-intubation (Table 4). Respira-
tory failure after extubation was defined as development 
of dyspnea symptoms within 12 hours after weaning. Of 
these 3 patients, 2 had post-operative atelectasis and 1 had 
acute lung injury due to multiple trauma. All were treated 
successfully by NIV without re-intubation. 
Factors predictive of the success of NIV
NIV was successful in 10 of 15 patients. Univariate and 
multivariate analysis showed that success was related to 
the etiology of ARF, especially atelectasis (P = 0.032). NIV 
was more likely to be successful in patients with post-
operative atelectasis, whereas invasive ventilation was 
more likely to be successful in patients with pneumonia. In 
contrast, patient age, gender, treatment with or immune 
suppressors, and the severity of respiratory function were 
not predictive of success (Table 2). 
DISCUSSION
We have shown here that surgical patients with ARF can 
be treated effectively with NIV. The likelihood of NIV suc-
cess is determined by the disease causing ARF not by the 
severity at the time of ARF or level of hypoxia. In partic-
ular, NIV was more likely to be successful in patients with 
postoperative atelectasis, whereas invasive ventilation 
was more likely to be successful in patients with 
pneumonia.
Although, hypoxia develops in 30 to 50% of patients af-
ter surgery, it improves slowly over several weeks in most 
patients without symptoms. In some patients, however, 
hypoxia can progress to dyspnea. Impaired gas exchange 
can be induced by the reduction in muscle tension caused Byoung Chul Lee, et al.
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by anesthesia, decreases in respiratory capacity, tidal vol-
ume, functional residual capacity and diaphragm dys-
function caused by surgery elevated abdominal pressure 
and pain. In particular, post-operative fluid therapy, trans-
fusion, inflammatory reaction, and sepsis are factors that 
aggravate respiratory failure. Positive pressure ven-
tilation may be the mainstay of ARF treatment. A random-
ized prospective study of patients who underwent thor-
aco-abdominal surgery for aortic aneurysm and were 
treated with CPAP or oxygen showed that CPAP de-
creased the rate of intubation, increased the level of oxy-
gen saturation and shortened hospital stay [16]. Other 
studies have also shown that positive pressure respiration 
after surgery is effective prophylactically in assisting pul-
monary function lost during surgery, and therapeutically 
in treating patients with post-operative respiratory fail-
ure, with NIV being successful in most patients [17-19].
During the initial period of NIV use in our institution, 
the mask did not adhere closely to the face, resulting in air 
leakage, skin compression by the mask and receipt of ex-
cessive pressure. Thus, the skin became necrotized and pa-
tients were quite uncomfortable, contributing to the NIV 
failure. Due to improvements of mask materials, espe-
cially the use of helmet masks that are not in direct contact 
with the patient’s face, patient discomfort and complica-
tions have been reduced, increasing patient compliance 
with NIV [11]. Moreover, nurses and physicians have 
gained more experience with NIV including both manipu-
lation methods and patient education. Thus, of our 15 pa-
tients treated with NIV therapy, only 5 (33.3%) were con-
verted to invasive ventilation during treatment, whereas 
the remaining 10 (66.7%) were treated successfully with 
NIV without endotracheal intubation. Others have also re-
ported that 30 to 50% of patients are converted to invasive 
ventilation requiring intubation. Factors predicting fail-
ure of NIV include pneumonia, disease severity, older age 
and lack of improvement 1 hour after application of NIV 
[20,21]. Among our 5 patients who failed NIV and were 
converted to invasive ventilation, compliance with NIV 
was determined within 3 days of its application and mean 
period of invasive ventilation after conversion was 27 
days, longer than in other patients who received mechan-
ical ventilation. Our findings suggest that the selection of 
appropriate indications for NIV is very important, and 
that the delay of appropriate treatments could prolong the 
treatment period.
In NIV, positive pressure ventilation is applied with the 
cooperation of patients, thus preventing hypotension 
caused by the use of sedatives, shortening treatment peri-
ods, reducing complications associated with intubation 
and reducing the incidence of pneumonia. Nonetheless, 
NIV may be associated with complications such as gastric 
distention and pulmonary aspiration, and NIV may im-
pede the ability of patients to cough and expectorate par-
ticularly in patients later converted to invasive ventilation. 
Of ARF patients weaned from mechanical ventilation as 
planned, 6 to 23% require re-intubation with 48 to 72 hours 
[22-24]. This is due primarily to obstruction of the upper 
airways, insufficient coughing or expectoration, deterio-
ration of consciousness, or myocardial failure. Although 
re-intubation reflects disease severity, intubation itself is 
an independent factor associated with increases in rates of 
pneumonia and death and duration of hospitalization 
[23,25]. Therefore, prevention of re-intubation is very im-
portant in the treatment of critically ill patients. In patients 
who developed respiratory failure after weaning, NIV was 
unable to lower mortality or re-intubation rate [25]. 
However high risk patients who received NIV soon after 
extubation, without re-intubation, could be successfully 
weaned from mechanical ventilation with a reduced mor-
tality rate within the intensive care unit [26]. Similarly, all 
3 of our patients who developed ARF after extubation 
were treated successfully with NIV without re-intubation.
Due to the retrospective design of our study, we could 
not control for factors such as the disease causing ARF at 
the time of therapeutic intervention, disease severity and 
clinical symptoms. This study , how ev er , is to compare 
NIV with invasive ventilation in surgical patients in 
Korea. Prospective analysis of the prophylactic and ther-
apeutic effects of NIV are therefore required. 
In conclusion, we found that NIV may be successful in 
surgical patients who develop ARF, particularly in se-
lected patients with post-operative atelectasis. The se-
verity of ARF or hypoxia at the time of intervention was 
not associated with the effects of NIV. Moreover, NIV can 
successfully prevent re-intubation in patients who devel-NIV for surgical patients with ARF
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op respiratory failure after extubation. 
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